Asian Journal of Pediatric Nephrology

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 4  |  Issue : 1  |  Page : 6--13

Vitamin d supplementation and bone health in children with nephrotic syndrome: A systematic review and meta-analysis


Rema G Caronan-Parallag1, Tristan Marvin Z. Uy2, Francisco E Anacleto3, Eric Emmanuel T. Aragon1, Lourdes Paula Real Resontoc1 
1 Department of Pediatrics, Division of Pediatric Nephrology, University of the Philippines - Philippine General Hospital, Manila, Philippines
2 Department of Pediatrics, Division of Pediatric Nephrology, University of the Philippines - Philippine General Hospital; Pediatric Infectious Disease and Tropical Medicine Department, San Lazaro Hospital, Manila, Philippines
3 Department of Pediatrics, Division of Pediatric Nephrology, University of the Philippines - Philippine General Hospital; Department of Physiology, College of Medicine, University of the Philippines, Manila, Philippines

Correspondence Address:
Lourdes Paula Real Resontoc
Department of Pediatrics, Division of Pediatric Nephrology, University of the Philippines-Philippine General Hospital, Taft Avenue, Manila 1000
Philippines

Background: While steroids have been the standard treatment in nephrotic syndrome (NS), they are known to deleteriously affect bone mineralization. Objectives: The objectives were to determine the efficacy and safety of vitamin D supplementation among children with NS on steroid therapy. Methods: We searched databases, scanned reference lists, and contacted trial investigators. Two reviewers collected and graded randomized controlled trials comparing oral vitamin D3 with placebo or no intervention in terms of bone mineral content/density (BMC/BMD), serum markers, and adverse events in pediatric NS. Results: We included 4 trials (164 subjects) with a collectively high risk of performance and/or detection bias. Although the vitamin D group had significantly more positive absolute change-from-baseline BMC than controls (mean difference 1.15; 95% CI 0.07-2-22;I 62%), the two trials were heterogeneous and included data. Moreover, in terms of other outcome measures, we did not find sufficient evidence of benefit from treatment. One study reported significantly improved parathyroid hormone levels but also a higher risk of hypercalciuria with vitamin D use. No nephrocalcinosis was reported. Subgroup analysis of first-episode NS revealed significantly more improved BMD with supplementation. Conclusion: Available evidence was low-quality and insufficient to recommend vitamin D supplementation in pediatric NS, although there may be benefit in first-episode NS. In contrast, vitamin D administration may be associated with hypercalciuria.


How to cite this article:
Caronan-Parallag RG, Z. Uy TM, Anacleto FE, T. Aragon EE, Real Resontoc LP. Vitamin d supplementation and bone health in children with nephrotic syndrome: A systematic review and meta-analysis.Asian J Pediatr Nephrol 2021;4:6-13


How to cite this URL:
Caronan-Parallag RG, Z. Uy TM, Anacleto FE, T. Aragon EE, Real Resontoc LP. Vitamin d supplementation and bone health in children with nephrotic syndrome: A systematic review and meta-analysis. Asian J Pediatr Nephrol [serial online] 2021 [cited 2022 Jan 17 ];4:6-13
Available from: https://www.ajpn-online.org/article.asp?issn=2589-9309;year=2021;volume=4;issue=1;spage=6;epage=13;aulast=Caronan-Parallag;type=0